Search - tctmd.com

Displaying 21 - 40 of 124

Sort: Relevancy | Date

Presentation TCT 2019

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Presenter: George Hanzel

September 27, 2019

Presentation TCT 2019

Optimal Timing for Surveillance Imaging After LAAC

Presenter: Saibal Kar

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Presentation TCT 2019

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

Presentation TCT 2019

LAA Closure in Patients With Prior Intracranial Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Presentation TCT 2019

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Presenter: Edip Gurol

September 26, 2019

Presentation TCT 2019

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

Presenter: William Gray

September 25, 2019

Presentation TCT 2019

TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography

Presenter: Kasper Korsholm

September 25, 2019

Presentation TCT 2019

TCT 115: The novel Watchman FLX for left atrial appendage closure. Early European experience.

Presenter: Jens Erik Nielsen-Kudsk

September 25, 2019

Presentation TCT 2019

TCT 114: Comparative Data on Left Atrial Appendage Occlusion Efficacy and Clinical Outcomes by Age Group in the Amplatzer Amulet Observational Study

Presenter: Xavier Freixa

September 25, 2019

Presentation TCT 2019

TCT 113: Adverse Events after Left Atrial Appendage Closure: Lessons Learned from the Manufacturer and User Facility Device Experience (MAUDE) database.

Presenter: Swaiman Singh

September 25, 2019

Presentation TCT 2019

Case 10 (From Taiwan): A Challenging LAA Closure

Presenter: Ying-Hsiang Lee

September 25, 2019

Advertisement

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Optimal Timing for Surveillance Imaging After LAAC

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

LAA Closure in Patients With Prior Intracranial Hemorrhage

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure in the United States: Update From the NCDR LAAO Registry

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography

TCT 115: The novel Watchman FLX for left atrial appendage closure. Early European experience.

TCT 114: Comparative Data on Left Atrial Appendage Occlusion Efficacy and Clinical Outcomes by Age Group in the Amplatzer Amulet Observational Study

TCT 113: Adverse Events after Left Atrial Appendage Closure: Lessons Learned from the Manufacturer and User Facility Device Experience (MAUDE) database.

Case 10 (From Taiwan): A Challenging LAA Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content